PCDHAC1: A Protein Regulator of Cytoskeleton and Tissue Development

Target Name: PCDHAC1

NCBI ID: G56135

PCDHAC1: A Protein Regulator of Cytoskeleton and Tissue Development

PCDHAC1 (PCDC1_HUMAN), a protein encoded in the human gene PCDC1, is a key regulator of the cytoskeleton and the organization of intracellular structures. It plays a crucial role in the development and maintenance of various tissues, including blood vessels, nervous system, and epithelial organs. Abnormal PCDHAC1 levels or disruptions in its function have been implicated in various diseases, including cancer, neurodegenerative disorders, and developmental defects. As a result, PCDHAC1 has emerged as a promising drug target or biomarker for a variety of diseases.

PCDHAC1 is a protein that belongs to the superfamily of cytoskeleton-associated proteins (CAPs) and is composed of 214 amino acid residues. It is expressed in various tissues, including blood vessels, heart, brain, and nervous system, and is involved in the PCDHAC1 is a key regulator of the cytoskeleton and plays a crucial role in the development and maintenance of various tissues.

PCDHAC1 functions as a negative regulator of the cytoskeleton by controlling the distribution and activity of other cytoskeleton-associated proteins. It does this by modulating the activity of several enzymes that are involved in the cytoskeleton, including the histone-modifying enzyme LATS1 and LC0. These enzymes are involved in the formation and maintenance of the cytoskeleton, and their activity is regulated by PCDHAC1.

PCDHAC1 is also involved in the regulation of cellular processes that are essential for tissue development and maintenance. For example, PCDHAC1 plays a role in the regulation of cell adhesion, migration, and the formation of tissues during development. of cell proliferation and apoptosis, which are critical processes for the development and maintenance of tissues.

Disruptions in PCDHAC1 function have been implicated in various diseases, including cancer, neurodegenerative disorders, and developmental defects. For example, studies have shown that PCDHAC1 is often overexpressed or downregulated in various tissues, including cancer cells, neurodegenerative disorders, and developmental defects. These Disruptions in PCDHAC1 function have been associated with the development of various diseases, including cancer, neurodegenerative disorders, and developmental defects.

In addition to its role in disease, PCDHAC1 has also been identified as a potential drug target or biomarker. Studies have shown that PCDHAC1 is highly expressed in various tissues, including blood vessels, heart, brain, and nervous system, which makes it an attractive target for drug development. Additionally, several studies have shown that PCDHAC1 is involved in the regulation of cellular processes that are essential for tissue development and maintenance, which makes it a potential biomarker for various diseases.

In conclusion, PCDHAC1 is a key regulator of the cytoskeleton and plays a crucial role in the development and maintenance of various tissues. Abnormal PCDHAC1 levels or disruptions in its function have been implicated in various diseases, including cancer, neurodegenerative disorders, and developmental defects. As a result, PCDHAC1 has emerged as a promising drug target or biomarker for a variety of diseases. Further research is needed to fully understand the role of PCDHAC1 in disease and to develop effective treatments.

Protein Name: Protocadherin Alpha Subfamily C, 1

Functions: Potential calcium-dependent cell-adhesion protein. May be involved in the establishment and maintenance of specific neuronal connections in the brain

More Common Targets